Provided by Tiger Trade Technology Pte. Ltd.

ASCENTAGE-B

47.660
+1.3602.94%
Volume:1.37M
Turnover:65.17M
Market Cap:17.78B
PE:-35.51
High:48.300
Open:46.300
Low:45.740
Close:46.300
52wk High:95.350
52wk Low:31.350
Shares:373.00M
HK Float Shares:373.00M
Volume Ratio:1.58
T/O Rate:0.37%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.342
ROE:-159.65%
ROA:-22.77%
PB:23.59
PE(LYR):-35.51
PS:40.22

Loading ...

Company Profile

Company Name:
ASCENTAGE-B
Exchange:
SEHK
Establishment Date:
2009
Employees:
605
Office Location:
Suzhou Industrial Park,68 Xinqing Road,Suzhou,Jiangsu Province,China
Zip Code:
215000
Fax:
- -
Introduction:
Ascentage Pharma Group International is an investment holding company primarily engaged in the discovery, development, and commercialization of therapies for hematologic malignancies. The Company's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The Company's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The Company primarily conducts its businesses in domestic market.

Directors

Name
Position
YANG Da Juan
Chairman of the Board,Executive Director
Benjamin Changqing Ye
Independent Director,Member of the Remuneration and Assessment Committee,Chairman of the Audit Committee
REN Wei
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee
David Sidransky
Independent Director,Independent Director,Chairman of the Nomination Committee,研发委员会委员
Debra Yu
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee
Marina Bozilenko
Independent Director,Member of the Audit Committee
Marc E. Lippman
Independent Director,Member of the Nomination Committee,研发委员会主席
WANG Shao Meng
Director,研发委员会委员
SIMON DAZHONG LU
Director,Member of the Audit Committee

Shareholders

Name
Position
YANG Da Juan
CEO
Thomas Joseph KNAPP
Vice General Manager,Advisor
CHEN Chao Man
Corporate Secretary
Raymond Jeffrey Kmetz
Chief Business Officer
DI Yi Fan
Other Senior Executives